David Nathanson

3.1k total citations
76 papers, 2.1k citations indexed

About

David Nathanson is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, David Nathanson has authored 76 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 18 papers in Cancer Research and 17 papers in Molecular Biology. Recurrent topics in David Nathanson's work include Breast Cancer Treatment Studies (12 papers), Diabetes Treatment and Management (12 papers) and Cancer Cells and Metastasis (9 papers). David Nathanson is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Diabetes Treatment and Management (12 papers) and Cancer Cells and Metastasis (9 papers). David Nathanson collaborates with scholars based in United States, Sweden and United Kingdom. David Nathanson's co-authors include Thomas Nyström, Johan Bodegård, Anna Norhammar, Marcus Thuresson, Jan W. Eriksson, Marianne Ulcickas Yood, Kåre I. Birkeland, Peter Fenici, Thomas Nyström and Christine Cole Johnson and has published in prestigious journals such as Journal of Clinical Investigation, Diabetes Care and JNCI Journal of the National Cancer Institute.

In The Last Decade

David Nathanson

70 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Nathanson United States 24 901 608 509 411 369 76 2.1k
Fabienne Thomas France 26 829 0.9× 516 0.8× 309 0.6× 163 0.4× 265 0.7× 109 2.0k
Atsuhiko Sakamoto Japan 28 1.0k 1.1× 618 1.0× 1.1k 2.1× 277 0.7× 648 1.8× 126 3.5k
Indraneel Mittra India 26 1.3k 1.4× 457 0.8× 299 0.6× 872 2.1× 223 0.6× 84 2.6k
Ruggero Dittadi Italy 24 847 0.9× 989 1.6× 122 0.2× 518 1.3× 113 0.3× 84 2.0k
Sun Young Min South Korea 24 430 0.5× 489 0.8× 180 0.4× 539 1.3× 403 1.1× 60 1.7k
Eli Rosenbaum Israel 34 1.0k 1.1× 1.7k 2.9× 787 1.5× 655 1.6× 615 1.7× 112 3.6k
Begoña de las Heras Spain 11 608 0.7× 318 0.5× 1.0k 2.0× 149 0.4× 229 0.6× 27 1.8k
Antonia Martinetti Italy 32 1.5k 1.7× 685 1.1× 274 0.5× 501 1.2× 278 0.8× 121 2.8k
Cinzia Orlandini Italy 29 2.2k 2.4× 622 1.0× 168 0.3× 630 1.5× 748 2.0× 74 3.7k
Peter Canney United Kingdom 25 1.3k 1.4× 359 0.6× 114 0.2× 535 1.3× 336 0.9× 77 2.6k

Countries citing papers authored by David Nathanson

Since Specialization
Citations

This map shows the geographic impact of David Nathanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Nathanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Nathanson more than expected).

Fields of papers citing papers by David Nathanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Nathanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Nathanson. The network helps show where David Nathanson may publish in the future.

Co-authorship network of co-authors of David Nathanson

This figure shows the co-authorship network connecting the top 25 collaborators of David Nathanson. A scholar is included among the top collaborators of David Nathanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Nathanson. David Nathanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jung, Michael E., et al.. (2024). DDDR-43. ERAS-801 IS A SELECTIVE BRAIN-PENETRANT EGFR INHIBITOR WITH IMPROVED ACTIVITY AGAINST EGFR EXTRACELLULAR DOMAIN-MUTANT GLIOBLASTOMA. Neuro-Oncology. 26(Supplement_8). viii135–viii135. 1 indexed citations
2.
Nathanson, David, et al.. (2022). Early breast cancer survival of black and white American women with equal diagnostic and therapeutic management. European Journal of Surgical Oncology. 49(3). 583–588. 2 indexed citations
3.
Bodegård, Johan, Viveca Ritsinger, Marcus Thuresson, et al.. (2022). Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data. Cardiovascular Diabetology. 21(1). 282–282. 4 indexed citations
4.
Nathanson, David, Michael Detmar, Timothy P. Padera, et al.. (2021). Mechanisms of breast cancer metastasis. Clinical & Experimental Metastasis. 39(1). 117–137. 42 indexed citations
5.
Nathanson, David. (2020). ASO Author Reflections: Is Breast Cancer Dissemination Lymphatic, Hematogenous, or Both; and Does It Matter?. Annals of Surgical Oncology. 27(S3). 711–712.
6.
Nathanson, David, David N. Krag, Henry M. Kuerer, et al.. (2018). Breast cancer metastasis through the lympho-vascular system. Clinical & Experimental Metastasis. 35(5-6). 443–454. 34 indexed citations
7.
Neugut, Alfred I., Grace Clarke Hillyer, Lawrence H. Kushi, et al.. (2016). A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL). Breast Cancer Research and Treatment. 158(1). 127–138. 17 indexed citations
8.
Nyström, Thomas, Johan Bodegård, David Nathanson, et al.. (2015). First-line and intensified treatment with glucose lowering drugs in the Swedish type 2 diabetes population. Diabetologia. 58. 1 indexed citations
9.
Bodegård, Johan, David Nathanson, Thomas Nyström, et al.. (2015). Second-line treatment with sulfonylurea compared to DPP4 inhibitors demonstrated associations with earlier treatment intensification with insulin. Diabetologia. 58. 4 indexed citations
10.
Nathanson, David, Christian Berne, Lars Lind, et al.. (2010). Plasma levels of glucagon like peptide‐1 associate with diastolic function in elderly men. Diabetic Medicine. 28(3). 301–305. 20 indexed citations
11.
Tarcic, Gabi, Shlomit Boguslavsky, Tai Kiuchi, et al.. (2009). An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR Endocytosis. Current Biology. 19(21). 1788–1798. 92 indexed citations
12.
Brown, Stephen L., Svend O. Freytag, Kenneth Barton, et al.. (2007). Reporter gene imaging using radiographic contrast from nonradioactive iodide sequestered by the sodium–iodide symporter. Contrast Media & Molecular Imaging. 2(5). 240–247. 4 indexed citations
13.
Cooper, Gregory S., Christine Cole Johnson, Lois Lamerato, et al.. (2006). Use of Guideline Recommended Follow-Up Care in Cancer Survivors. Medical Care. 44(6). 590–594. 22 indexed citations
14.
Nathanson, David. (2003). Insights into the mechanisms of lymph node metastasis. Cancer. 98(2). 413–423. 345 indexed citations
15.
Stark, Azadeh, et al.. (2002). Evaluating Post‐Treatment Screening in Women with Breast Cancer. Cancer Practice. 10(5). 228–233.
16.
Velanovich, Vic, Frank R. Lewis, David Nathanson, et al.. (1999). Comparison of Mammographically Guided Breast Biopsy Techniques. Annals of Surgery. 229(5). 625–625. 78 indexed citations
17.
18.
Nathanson, David, et al.. (1993). Irrigation does not dislodge or destroy tumor cells adherent to the tumor bed. Journal of Surgical Oncology. 53(3). 184–190. 31 indexed citations
19.
Cerra, R. F. & David Nathanson. (1991). Chemotactic activity present in liver extracellular matrix. Clinical & Experimental Metastasis. 9(1). 39–49. 7 indexed citations
20.
Nathanson, David. (1990). Changes Associated With Metastasis in B16-F1 Melanoma Cells Surviving Heat. Archives of Surgery. 125(2). 216–216. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabienne Thomas Breakdown of academic impact, for papers by Atsuhiko Sakamoto Breakdown of academic impact, for papers by Indraneel Mittra Breakdown of academic impact, for papers by Ruggero Dittadi Breakdown of academic impact, for papers by Sun Young Min Breakdown of academic impact, for papers by Eli Rosenbaum Breakdown of academic impact, for papers by Begoña de las Heras Breakdown of academic impact, for papers by Antonia Martinetti Breakdown of academic impact, for papers by Cinzia Orlandini Breakdown of academic impact, for papers by Peter Canney
Rankless by CCL
2026